Lithium Hydroxide → HCID 71186520, compound
Reaction equation
[F:1][C:2]([F:35])([F:34])[C:3]1[N:8]=[CH:7][C:6]([CH2:9][N:10]2[CH2:17][CH2:16][C:13]3([CH2:15][CH2:14]3)[CH2:12][CH:11]2[C:18]([NH:20][C:21]2([C:24]3[CH:33]=[CH:32][C:27]([C:28]([O:30]C)=[O:29])=[CH:26][CH:25]=3)[CH2:23][CH2:22]2)=[O:19])=[CH:5][CH:4]=1.[Li+].[OH-]>>[F:35][C:2]([F:1])([F:34])[C:3]1[N:8]=[CH:7][C:6]([CH2:9][N:10]2[CH2:17][CH2:16][C:13]3([CH2:15][CH2:14]3)[CH2:12][CH:11]2[C:18]([NH:20][C:21]2([C:24]3[CH:33]=[CH:32][C:27]([C:28]([OH:30])=[O:29])=[CH:26][CH:25]=3)[CH2:22][CH2:23]2)=[O:19])=[CH:5][CH:4]=1Participants
3
Procedure
The title compound (E8) (35 mg) was prepared according to the general procedure for esters hydrolysis (Method D) starting from methyl 4-(1-(6-((6-(trifluoromethyl)pyridin-3-yl)methyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl)benzoate (D124) (47 mg). (LiOH: 4 eq; Reaction time: 5 hrs; RT)
Sources & evidence
- ORD record
- ord-cc878bbf69a943a09b53e733043d8296
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181279B2
Reaction notes
Loading…